Cuba Develops New Cancer Treatment Amid U.S. Embargo
- Published:
- First detected:
Insights by Echo AI
Cuba's Molecular Immunology Center (CIM) has created a new therapeutic candidate, 2C12, for treating advanced melanoma. This drug aims to enhance the body's immune response against cancer cells. The development comes due to difficulties in accessing oncological drugs internationally, exacerbated by the U.S. embargo and economic crisis. The first clinical study will begin in Havana hospitals.
Source coverage
4
records merged
3
2 unique
0
0 unique
1
1 unique
4 Sources
🚨 Cuba desarrolla un tratamiento contra el cáncer ante el bloqueo al p...
🚨 Cuba desarrolla un tratamiento contra el cáncer ante el bloqueo al p...
Ante la crisis de medicinas, Cuba anuncia nuevo tratamiento contra el...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
